Orchestra BioMed Holdings, Inc. is an innovative therapeutic device company based in New Hope, Pennsylvania, focused on developing cutting-edge treatments for cardiovascular diseases. The firm's product portfolio includes advanced medical devices designed to address significant unmet clinical needs, leveraging its proprietary technologies to improve patient outcomes. With a commitment to enhancing the quality of care in cardiology, Orchestra BioMed aims to transform therapeutic approaches and expand access to effective cardiovascular solutions, positioning itself as a leader in the evolving healthcare landscape.
Click "Analyze" to generate stock analysis
OBIO Price Trend and Signals
OBIO Option Volumes & Open Interests (aggregated)
OBIO Put Call Ratios and IV (aggregated)
OBIO Financials
2025-10-24Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Bullishprice_signal
Large price change detected: 17.47%.
2025-10-16Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-15Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-14Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-13Somewhat Bullishprice_signal
Monthly high detected.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-10Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.